Challenges and Prospects for Designer T and NK Cells in Glioblastoma Immunotherapy

por Arnesen, Victoria Smith, Gras Navarro, Andrea, Chekenya, Martha
Publicado 2021

Class I Phosphoinositide 3-Kinase PIK3CA/p110α and PIK3CB/p110β Isoforms in Endometrial Cancer

por Mazloumi Gavgani, Fatemeh, Smith Arnesen, Victoria, Jacobsen, Rhîan G., Krakstad, Camilla, Hoivik, Erling A., Lewis, Aurélia E.
Publicado 2018

Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions

por Blakstad, Hanne, Brekke, Jorunn, Rahman, Mohummad Aminur, Arnesen, Victoria Smith, Miletic, Hrvoje, Brandal, Petter, Lie, Stein Atle, Chekenya, Martha, Goplen, Dorota
Publicado 2023

Nuclear Phosphatidylinositol 3,4,5-Trisphosphate Interactome Uncovers an Enrichment in Nucleolar Proteins

por Mazloumi Gavgani, Fatemeh, Slinning, Malene Skuseth, Morovicz, Andrea Papdiné, Arnesen, Victoria Smith, Turcu, Diana C., Ninzima, Sandra, D’Santos, Clive S., Lewis, Aurélia E.
Publicado 2021

Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study

por Rahman, Mohummad A., Brekke, Jorunn, Arnesen, Victoria, Hannisdal, Marianne H., Navarro, Andrea G., Waha, Andreas, Herfindal, Lars, Rygh, Cecilie B., Bratland, Eirik, Brandal, Petter, Haasz, Judit, Oltedal, Leif, Miletic, Hrvoje, Lundervold, Arvid, Lie, Stein A., Goplen, Dorota, Chekenya, Martha
Publicado 2020